1 June 2023 - The drugs may force reform to Medicaid.

The vial is familiar, the liquid inside could be water—but the price tag is a little more unusual. A shot of Zolgensma, a gene therapy for spinal-muscular atrophy, comes to $2.1 million. It is one of a new generation of ultra-expensive medicines. Treatments for beta-thalassaemia and haemophilia, two blood disorders, cost $2.8 million and $3.5 million, respectively.

Read The Economist article